Shorter is better: Difference between revisions
From IDWiki
No edit summary |
m (Text replacement - "Intra-abdominal infections]]" to "Intra-abdominal infection]]") |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== |
==AMMI== |
||
{| class="wikitable" |
{| class="wikitable" |
||
!Infection |
!Infection |
||
| Line 7: | Line 7: | ||
! colspan="3" |Urinary Tract Infections |
! colspan="3" |Urinary Tract Infections |
||
|- |
|- |
||
|Women or |
|Women or adolescents with uncomplicated [[cystitis]] |
||
|[[Nitrofurantoin]] for 5 days, [[TMP-SMX]] for 3 days, [[fosfomycin]] for 1 day |
|[[Nitrofurantoin]] for 5 days, [[TMP-SMX]] for 3 days, [[fosfomycin]] for 1 day |
||
|young non-pregnant female adolescents or adults with normal urinary tracts and normal renal function |
|young non-pregnant female adolescents or adults with normal urinary tracts and normal renal function |
||
| Line 102: | Line 102: | ||
|} |
|} |
||
== |
==Brad Spellberg== |
||
{| class="wikitable" |
{| class="wikitable" |
||
!Diagnosis |
!Diagnosis |
||
| Line 128: | Line 128: | ||
|7 |
|7 |
||
|- |
|- |
||
|[[Intra-abdominal |
|[[Intra-abdominal infection]] |
||
|4 |
|4 |
||
|10 |
|10 |
||
Latest revision as of 14:27, 10 March 2022
AMMI
| Infection | Duration | Comments |
|---|---|---|
| Urinary Tract Infections | ||
| Women or adolescents with uncomplicated cystitis | Nitrofurantoin for 5 days, TMP-SMX for 3 days, fosfomycin for 1 day | young non-pregnant female adolescents or adults with normal urinary tracts and normal renal function |
| Children with febrile urinary tract infection | 7 to 14 days | assumes upper tract involvement if febrile |
| Adults with pyelonephritis and urosepsis | consider initial dose of IV; quinolones or beta-lactams for 7 days | excludes patients with urogenital abnormalities, stents, or drains; duration depends on clinical response |
| Respiratory Tract Infections | ||
| Streptococcal pharyngitis | 10 days (penicillin V or amoxicillin) | studies limited to pediatrics |
| Acute otitis media | 10 days (6 months to 2 years) or 5 days (over 2 years) | if moderately to severely ill with bulging tympanic membrane |
| Acute uncomplicated sinusitis | 5 to 7 days | reassess at 7 days |
| Community-acquired pneumonia | 5 to 7 days | excludes patients with underlying lung disease, immunosuppression, and empyema; depends on clinical response |
| Hospital-acquired pneumonia | ≤7 days | excludes severely immunosuppressed patient or those with collections/abscesses |
| Acute exacerbation of COPD | 5 to 7 days | only if antibiotics are indicated |
| Intra-abdominal Infections | ||
| Uncomplicated appendicitis | pre-operative antibiotics only | if gangrenous or perforated, continue for additional 24 to 48 hours after source control |
| Traumatic bowel perforation | up to 24 hours post-operatively | if operated on within 12 hours of trauma |
| Gastroduodenal perforation | up to 24 hours post-operatively | if operated on within 24 hours |
| Intra-abdominal abscess | <7 days | if source control is adequate, regardless of whether drainage is still in place |
| Skin Infections | ||
| Uncomplicated cellulitis | 5 to 7 days | |
| Bone and Joint Infections | ||
| Children with acute osteomyelitis | 3 to 4 weeks | transition to oral therapy once clinically improving and CRP decreasing |
| Adults with acute vertebral osteomyelitis | 6 weeks | excludes those with implantable devices; may be longer for Salmonella or Brucella |
| Adults with acute septic arthritis | 2 weeks (small joints) or 4 weeks (large joints) | duration after surgical drainage |
| Bacteremia | ||
| Enterobacterales | 7 days | if source control and not associated with syndrome requiring longer therapy |
| Staphylococcus aureus (uncomplicated) | 14 days (IV) | if other focusses are excluded |
| Staphylococcus aureus (complicated) | 4 to 6 weeks (IV) | |
| Streptococcus pneumoniae, with pneumonia | 5 to 7 days | if clinically improving |
Brad Spellberg
| Diagnosis | Short (d) | Long (d) | Result | # RCTs |
|---|---|---|---|---|
| Community-acquired pneumonia | 3-5 | 5-14 | = | 10 |
| Ventilator-associated pneumonia | 8 | 15 | = | 2 |
| Pyelonephritis | 5-7 | 10-14 | = | 7 |
| Intra-abdominal infection | 4 | 10 | = | 2 |
| Gram-negative bacteremia | 7 | 14 | = | 2 |
| Cellulitis | 5-6 | 10 | = | 4 |
| Chronic osteomyelitis | 42 | 84 | = | 2 |
| Diabetic foot osteomyelitis, after debridement | 21 | 42 | = | 1 |
| Septic arthritis | 14 | 28 | = | 1 |
| Removed orthopedic implant | 28 | 42 | = | 1 |
| Acute exacerbation of COPD or sinusitis | ≤5 | ≥7 | = | >25 |
| Febrile neutropenia | Afebrile x72 h | + ANC >500 | = | 1 |
| Latent tuberculosis infection | 1-4 mo | 6-12 mo | = | 8 |
| Plasmodium vivax malaria | 7 | 14 | = | 1 |
Further Reading
- Brad Spellber's Shorter is Better website
- AMMI Practice Point: Duration of Antibiotic Therapy for Common Infections
